Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Persaud

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Journal of Virus Eradication|October 27, 2016
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USAJeymohan Joseph, Paola Cinque, Deborah Colosi, et al.
Journal of Virology|June 16, 2006
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsJustin R Bailey, Ahmad R Sedaghat, Tara Kieffer, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
Microbiology Spectrum|June 6, 2022
Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative StudyYann Le Duff, Kathleen Gärtner, Eloise J Busby, et al.
AIDS (London, England)|May 30, 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapyThor A Wagner, Camlin Tierney, Sharon Huang, et al.
The Lancet. HIV|September 27, 2025
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept studyDeborah Persaud, Anne Coletti, Bryan S Nelson, et al.
AIDS Research and Human Retroviruses|October 28, 2024
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, et al.
The Journal of Infectious Diseases|March 14, 2013
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoireJoseph P Casazza, Kathryn A Bowman, Selorm Adzaku, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Journal of Virus Eradication|October 27, 2016
Highlights of the Global HIV-1 CSF Escape Consortium Meeting, 9 June 2016, Bethesda, MD, USAJeymohan Joseph, Paola Cinque, Deborah Colosi, et al.
Journal of Virology|June 16, 2006
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cellsJustin R Bailey, Ahmad R Sedaghat, Tara Kieffer, et al.
The Lancet. HIV|December 7, 2023
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept studyDeborah Persaud, Yvonne Bryson, Bryan S Nelson, et al.
Microbiology Spectrum|June 6, 2022
Assessing the Variability of Cell-Associated HIV DNA Quantification through a Multicenter Collaborative StudyYann Le Duff, Kathleen Gärtner, Eloise J Busby, et al.
AIDS (London, England)|May 30, 2024
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapyThor A Wagner, Camlin Tierney, Sharon Huang, et al.
The Lancet. HIV|September 27, 2025
ART-free HIV-1 remission in children with in-utero HIV-1 after very early ART (IMPAACT P1115): a multicentre, open-label, phase 1/2 proof-of-concept studyDeborah Persaud, Anne Coletti, Bryan S Nelson, et al.
AIDS Research and Human Retroviruses|October 28, 2024
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, et al.
The Journal of Infectious Diseases|March 14, 2013
Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoireJoseph P Casazza, Kathryn A Bowman, Selorm Adzaku, et al.
AIDS Research and Human Retroviruses|May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop SummaryBrigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Pageof 9